Abstract It is now clear that inflammation plays a key role in atherogenesis. As a matter of fact, signs of inflammation of atherosclerotic plaques have been observed for centuries and also constituted the basis for a fierce controversy in the 19th century between the prominent Austrian pathologist Carl von Rokitansky and his German counterpart, Rudolf Virchow. While the former attributed a secondary role to these inflammatory arterial changes, Virchow considered them to be of primary importance. We had the unique opportunity to address this controversy by investigating atherosclerotic specimens from autopsies performed by Carl von Rokitansky up to 178 years ago.
Introduction
Atherosclerosis is a disease that has plagued mankind for millennia, as exemplified by findings of degenerative changes in the aorta, coronary, and peripheral arteries of Egyptian mummies [13, 14, 27] . These lesions from ancient Egyptians are no different from those currently observed in vascular surgery and morbid histology.
Medical researchers began to take a closer look at vascular alterations in the beginning of the 19th century. In 1829, the German-born French surgeon and pathologist Jean Lobstein introduced the term "arteriosclerosis" in his unfinished Traité d'Anatomie Pathologique, a four-volume treatise on pathological anatomy, based upon his lifelong personal experience [6] .
In the middle of the 19th century, two opposing schools of pathology, that of Rudolf Virchow in Berlin, Germany, and that of Carl von Rokitansky in Vienna, Austria, described cellular inflammatory changes in atherosclerotic vessel walls [11, 17] . Although von Rokitansky considered these changes secondary in nature, Virchow supported their primary role in atherogenesis. Contrary to the "humoral pathology" and the "crases" theory of the Viennese school, Virchow saw the causes of diseases in changes of cells and coined the term "cellular pathology".
Virchow strongly criticized Carl von Rokitansky and the Viennese Medical School for their dogmatism and support of outdated humoralism. In fact, the humoral disease theory included in the first edition of Rokitansky's famous pathology textbook "A Manual of Pathological Anatomy" was eliminated entirely from the second edition.
In 1910, the German chemist Windaus showed that atherosclerotic plaques consist of calcified connective tissue and cholesterol [23] . Three years later, Anitschkow and Chaltow succeeded in inducing atherosclerosis in rabbits by feeding a cholesterol-rich diet [1] unequivocally identifying a classical risk factor for progression of atherosclerotic alterations. Several other risk factors, such as smoking, high blood pressure, high emotional stress, improper diet, diabetes, etc., were later found to contribute to disease progression.
However, the crucial first pathogenetic events of the disease remained unclear. Classical concepts of atherogenesis did not attribute a major relevance to inflammatoryimmunologic processes as possible pathogenetic factors. A comprehensive review on historical papers dealing with inflammatory aspects of atherosclerosis has been compiled by Nieto [9] .
The "response to injury hypothesis", summarized by Ross in 1993, originally postulated an alteration of the endothelium and intima due to, e.g., mechanical injury, toxins, and oxygen radicals, as the initiating event leading to endothelial dysfunction [12] .
Alternatively, the "altered lipoprotein hypothesis", favored by Steinberg and others, postulated an initiating role of chemically altered lipoproteins, notably oxidized low-density lipoprotein (oxLDL), leading to the primary formation of foam cells in the intima [16] . The group of Fogelman [8] pointed out that native LDL, rather than oxLDL, is transported into the intima through the endothelium, where it is then modified and retained, acting as a chemoattractant for monocytes and smooth muscle cells (SMC), and being later taken up by these cells, resulting in foam cell formation. This concept was termed the "retention of modified LDL hypothesis". However, atherogenesis seems to be a far more complex process than simple lipid deposition.
Intriguingly, accumulations of activated T cells, macrophages, and dendritic cells were identified in severely afflicted arteries [2] and were also found to be common in arteries of young adults and even children, at predilection sites for the later occurrence of atherosclerotic lesions [18, 25] . We have called these foci of intimal mononuclear cells the "vascular-associated lymphoid tissue"-VALT [7, 22] . With respect to these findings, the question arose, as to which antigens are recognized by the immune system, leading to a local immune reaction in the arterial wall. An extended series of experiments revealed a stress protein, heat shock protein 60 (HSP 60), as the potential (auto) antigen inciting an immune response at the beginning of atherosclerotic changes in the vessel wall [4, 24] . Classical atherosclerosis risk factors, such as high blood pressure, smoking, diabetes, biochemically modified LDL, etc., result in the expression of HSP60 by endothelial cells (EC), especially at sites that are subjected to major (turbulent) haemodynamic stress and known to be predilection sites for the later development of atherosclerotic lesions. Thus, pre-existing cellular and humoral immunity to microbial HSP60 may encompass pathogenetically relevant crossreactivity with HSP60 expressed on the surface of arterial EC and leads to the initial inflammatory stage of atherosclerosis [10] . In addition, bona fide autoimmunity triggered by biochemically altered autologous HSP60 may also occur [26] . Based on this concept, the "immunological hypothesis" of atherogenesis was formulated [21] . Accordingly, the latter results strongly support Virchow's theory of atherosclerosis as a primarily inflammation-induced disease.
We recently had the unique opportunity to investigate paraffin sections of early atherosclerotic lesions from specimens secured by von Rokitansky in the middle of the 19th century, which were stored in the archives of the Institute for Pathological Anatomy, Vienna. We used these historical materials to confirm the presence and role of an early inflammatory process in atherogenesis, and also present methodological data on the successful use of various modern immunohistochemical techniques on such historical resources.
Materials and methods
Twelve atherosclerotic arteries, originally collected between 1827 and 1885, were selected from the Collection of Pathological Specimens procured by Rokitansky and thereafter stored at the Federal Museum of Pathological Anatomy, Vienna, Austria (see Table 1 ). In the early 19th century, specimens were stored in pure alcohol ("Weingeist"), and subsequently in "Kaiserling's fluid" (750 ml formaldehyde, 1,000 ml distilled water, 10 g potassium nitrate, 30 g potassium acetate) [15] . In the beginning of the 20th century, Kaiserling's fluid was replaced with lower graded formaldehyde to preserve tissue to the present [3] . Historical human lymph node (1893) and human skin (1849) proved to be unusable as positive control tissue as either black deposits (lymph node) or section detachment from the slides made successful processing impossible. Formaldehyde (4% formaldehyde in phosphate buffered saline, PBS, pH 7.2)-fixed recent samples of human skin, tonsil, lymphnode, and arterial fragments were, therefore, used for control purposes. For the final analysis, 3 of 12 vessels were excluded because of signs of autolytic degeneration. Historical and contemporary tissues were dehydrated and paraffin embedded. Sections 5-μm thick were cut and placed onto silane-coated slides. Sections were rehydrated and the crucial step of antigen retrieval was performed either with proteinase XXIV (P8038, Sigma, 1 mg/ml in PBS, 5-min incubation) or microwave irradiation (750 W, Microscopic analyses were carried out either with a Nikon Eclipse E800 microscope or a Zeiss Axiovert 100M confocal laser scanning microscope.
Results
Immunohistochemical and immunofluorescence analyses using monoclonal and polyclonal antibodies recognizing Table 1 ). Original magnification ×400; b negative control-rabbit Ig fraction; aorta ascendens, 51-year-old male died in 1878 (MN3590). Original magnification ×400; c Von Willebrand factor (red); arterial intima, male (age unknown) died in 1837 (MN1819). Original magnification ×200; d Negative controlrabbit Ig fraction; arterial intima, male (age unknown) died in 1837 (MN1819). Original magnification ×200; e Fibronectin (red); arterial intima; male (age unknown) died in 1837 (MN1819). Original magnification ×200; f Negative controlnormal rabbit serum; male (age unknown) died in 1837 (MN1819). Original magnification × 200; g Collagen type IV (red); arteria lienalis, 47-year-old male died in 1831 (MN1347). Original magnification ×200; h Negative controlmouse IgG1, arteria 47-year-old male died in 1831 (MN1347) various cell surface markers, adhesion molecules, and extracellular matrix (ECM) components were adapted and successfully used for these studies. The T-cell surface marker CD3, the endothelial marker von Willebrand factor (vWF), and the epitopes of the extracellular matrix proteins collagen type I, III, and IV and fibronectin were preserved and, thus, could be visualized.
In two of nine vessels, CD3-positive cells could be detected in atherosclerotic lesions (Fig. 1a) . To exclude unspecific staining, negative controls were also performed showing no staining (Fig. 1b) . None of the historical vessels were positive for the macrophage surface marker CD68, the smooth muscle cell antigen alpha-actin, the dendritic cell marker S100, HLA-DR (MHC II), a fibroblast marker as well as the adhesion molecules CD62-P (Pselectin) or CD106 (vascular cell adhesion molecule-1-VCAM-1) (see Table 3 ). In contrast, vWF was found in the vasa vasorum of almost all vessels examined. However, only a few specimens also showed a vWF positive endothelium lining the main arterial lumen (Fig. 1c,d ). Fibronectin-expressing structures were present ubiquitously in almost all analyzed lesions, particularly in adventitia and thickened areas of the intima (Fig. 1e,f) . In half of the arteries, collagen type IV-positive structures were found in the vasa vasorum (Fig. 1g,h) . A specimen of the arteria lienalis additionally showed collagen type IVpositive filaments in intima and media. Collagen type I was also detected in the adventitia and media of two vessels (Fig. 2a) . All atherosclerotic lesions examined showed abundant collagen type III in the adventitia and media. In contrast, collagen type III-positive fibres were rarely found in the intima (Fig. 2b-d) .
Discussion

Methodological aspects
Human pathological specimens have been collected and stored in anatomical museums for centuries [15] . This large pool of historical material could, in principle, serve as a rich resource for various types of research. However, thus far, only a limited number of methods were available for the examination of such sensitive samples, and immunohistochemistry could not be successfully implemented [15] . Our laboratory has extensive experience in this area [19] and, in fact, introduced immunohistological techniques into paleontological research, thus creating a new subdiscipline, paleoimmunology [20] .
The arterial vessels examined derived from pathological human samples collected by von Rokitansky and his antecessor Wagner and successor Heschl between 1827 and 1885. Intriguingly, autopsy reports compiled approximately 170 years ago are often still available [15] , a remarkable sign of a well-organized storage system throughout the centuries.
Implementing the application of modern immunological techniques to atherosclerosis research has been a challenge, as available supply of historical arteries was limited, and some vessels had to be excluded due to autolytic degeneration. The historical control tissues, intended to be used for establishing the assays, turned out to be unsuitable due to black deposits of unknown origin. Additionally, some of the chemicals used for tissue fixation and storage conditions (exposure to light or air) might have altered the specimens. The sensitivity of different epitopes to the extraordinary extended fixation time (up to 17 decades) is clearly distinguished by comparing the results found with polyclonal and monoclonal antibodies, respectively. CD3, vWF, collagen type I, collagen type III, fibronectin positive fibers and cells were all detected with polyclonal antibodies, whereas, monoclonal antibodies generally failed to detect these structures, with the exception of collagen type IV, in historical tissue. In view of the unique nonfibrillar procollagen-like structure of collagen type IV, which includes several non-helical domains that are susceptible to conventional proteases, the latter observation was rather surprising. It is, thus, probable that epitopes in tissue specimens, especially after extended fixation time and harsh storage conditions, deteriorate or are masked by chemical processes such as methylen bridges formed between reactive sites of tissue proteins. Thus, destruction or masking of the epitope recognized by a monoclonal antibody results in the lack of any signal. On the other hand, the use of a polyclonal antibody greatly enhances the possibility that at least one of the several epitopes these immunoglobulins bind to has resisted deterioration. Accordingly, the antigen retrieval procedure, has turned out to be a crucial step. Finally, the optimal technique for visualization of histological structures in historical tissue samples, i.e., immunohistochemistry or immunofluorescence, must be determined for each antigen-antibody system in pilot studies.
General aspects
It has long been known that both humoral and cellular immune reactions take place in atherosclerotic lesions, but it has not been clear whether these processes were primary or secondary in nature. Already in the middle of the 19th century, Carl von Rokitansky and Rudolf Virchow pointed out an association of histologic signs of inflammation with atherosclerotic lesions. Both described cellular inflammatory changes in atherosclerotic vessel walls, but while von Rokitansky considered these changes secondary in nature, Virchow supported their primary role in atherogenesis.
Atherosclerosis is a multifactorial disease, and advanced lesions are by definition complex encompassing various inflammatory and non-inflammatory hallmarks [28] . In principle, one can distinguish three major types of this disease, viz.
(a) Those that develop exclusively on a genetic basis and for which valuable murine knockout models have been developed [29] , e.g., familial hypercholesterolemia (FH) due to a heterozygous or homozygous deficiency of the LDL receptor on one end of the spectrum. collagenous and non-collagenous extracellular matrix proteins. Endothelial cells in the atherosclerotic region differ in their expression of adhesion molecules from other, non-affected vascular territories [7] . Macrophages and smooth muscle cells possess non-saturable scavenger receptors and are transformed into foamcells that have the tendency to disintegrate and release their lipid-rich content into the extracellular space where cholesterol crystals may even be formed. Lymphocytes are preferentially of the Th1 phenotype and include both, effector and regulatory cells, as reflected by their respective cytokine profiles [28] . B cells are scarce, both in early as well as in late lesions [4, 7] , but antibodies against plaque antigens, inhibitory Fcreceptors, and cytokines are deemed to play a major role in the advanced atherogenic process [30] .
It now seems clear that inflammatory immunologic processes on an appropriate genetic background are operative in incipient atherogenesis, but the very first pathogenetic event remains to be elucidated. In our "autoimmune concept of atherogenesis" [21] , we postulate that classical atherosclerosis risk factors, such as hypertension, smoking, diabetes, the life-long infectious load or an altered lipid metabolism first act as stressors of endothelial and intimal cells leading to the expression of HSP60 that then triggers adaptive and innate immune processes that start the disease. With respect to the activity of oxidized LDL as an endothelial stressor, it is of interest that lipid-lowering statins have anti-inflammatory [31] and immunosuppressive [32] effects. The initiating role of adaptive immune mechanisms is, e.g., supported by the fact that atherosclerosis can be induced in normocholesterolemic rabbits by immunization with recombinant HSP60 [24] and that the transfer of the disease in mice is possible by both anti-HSP60 antibodies [33] or T cells [34] . Alternatively, components of the innate immune system operative via the activation of Toll-like receptors (TLRs) [35] or in the form of natural killer T (NKT) [36] cells may initiate the disease.
Immunohistological studies in rabbits and humans have identified activated T cells as the first intima-infiltrating elements, clearly preceding macrophages and smooth muscle cells [25] . The present results further support our previous findings that CD3 + T cells are present in the earliest phases of atherosclerosis and, thus, seem to agree with Virchow's view that inflammation plays a primary role in initiating the atherogenic process rather than Rokitansky's concept assigning them a secondary role only.
This investigation of historical biological sources and the application of modern technologies thereto has opened new perspectives for the use of this valuable material for all types of pathohistological studies.
